BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22595378)

  • 21. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.
    Berghella V; Figueroa D; Szychowski JM; Owen J; Hankins GD; Iams JD; Sheffield JS; Perez-Delboy A; Wing DA; Guzman ER;
    Am J Obstet Gynecol; 2010 Apr; 202(4):351.e1-6. PubMed ID: 20350641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between fetal fibronectin and spontaneous preterm birth in twin pregnancies with a shortened cervical length
    Matthews KC; Gupta S; Lam-Rachlin J; Saltzman DH; Rebarber A; Fox NS
    J Matern Fetal Neonatal Med; 2018 Oct; 31(19):2564-2568. PubMed ID: 28651447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17-alphahydroxyprogesterone caproate in women with previous spontaneous preterm delivery: does a previous term delivery affect the rate of recurrence?
    Barton JR; Barton LA; Istwan NB; Rhea DJ; Desch CN; Sibai BM
    Am J Obstet Gynecol; 2011 Sep; 205(3):269.e1-6. PubMed ID: 22071060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
    Zhou MX; Zhou J; Bao Y; Chen YQ; Cai C
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
    Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
    Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.
    Manuck TA; Stoddard GJ; Fry RC; Esplin MS; Varner MW
    Am J Obstet Gynecol; 2016 Nov; 215(5):622.e1-622.e8. PubMed ID: 27418444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Merlob P; Stahl B; Klinger G
    Reprod Toxicol; 2012 Jan; 33(1):15-9. PubMed ID: 22120850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
    Nikolova T; Bayev O; Nikolova N; Di Renzo GC
    J Perinat Med; 2015 Jul; 43(4):395-402. PubMed ID: 25562603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women.
    Jwala S; Tran TL; Terenna C; McGregor A; Andrel J; Leiby BE; Baxter JK; Berghella V
    Acta Obstet Gynecol Scand; 2016 Aug; 95(8):948-55. PubMed ID: 27100022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.
    Nelson DB; McIntire DD; McDonald J; Gard J; Turrichi P; Leveno KJ
    Am J Obstet Gynecol; 2017 Jun; 216(6):600.e1-600.e9. PubMed ID: 28223163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fetal fibronectin test is superior to cervical length measurement in predicting preterm birth in twin pregnancies: a retrospective observational study.
    Holzer I; Koch-Trappel M; Leitich H; Meyer EL; Farr A; Helmer H
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():22-25. PubMed ID: 32058186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
    Rafael TJ; Mackeen AD; Berghella V
    Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of preterm delivery by fetal fibronectin in symptomatic and asymptomatic women with cervical length ≤20 mm.
    Magro-Malosso E; Seravalli V; Cozzolino M; Spitaleri M; Susini T; Di Tommaso M
    J Matern Fetal Neonatal Med; 2017 Feb; 30(3):294-297. PubMed ID: 27052846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between maternal biomarkers and pathways to preterm birth in twin pregnancies.
    Bergh E; Rebarber A; Oppal S; Saltzman DH; Klauser CK; Gupta S; Fox NS
    J Matern Fetal Neonatal Med; 2015 Mar; 28(5):504-8. PubMed ID: 24849127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical sonoelastography for improving prediction of preterm birth compared with cervical length measurement and fetal fibronectin test.
    von Schöning D; Fischer T; von Tucher E; Slowinski T; Weichert A; Henrich W; Thomas A
    J Perinat Med; 2015 Sep; 43(5):531-6. PubMed ID: 25720038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate.
    Rebarber A; Ferrara LA; Hanley ML; Istwan NB; Rhea DJ; Stanziano GJ; Saltzman DH
    Am J Obstet Gynecol; 2007 Mar; 196(3):224.e1-4. PubMed ID: 17346529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.